Document is current
Any future updates will be listed below
-
Authors
Haertlé, Juliane
Kienlin, Petra
Begemann, Gabriele
Werfel, Thomas
Roesner, Lennart M.
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 8 March 2023
Accepted: 12 September 2023
First Online: 3 October 2023
Competing interests
: L.M.R. lectured at educational events sponsored by Novartis outside the scope of this work. T.W. has received institutional research grants from LEO Pharma and Novartis, has performed consultancies for Abbvie, Janssen, Galderma, LEO, Sanofi-Genzyme, and Novartis, he has also lectured at educational events sponsored by Abbvie, Janssen, Celgene, Galderma, LEO Pharma, Sanofi and Novartis and is involved in performing clinical trials various pharmaceutical industries that manufacture drugs used for the treatment of psoriasis and atopic dermatitis. No other author reports conflict of interest.
